The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 316-325

  Tao, Xuelian ^a   Davis, Laurie S ^a   Hashimoto, Keisuke ^a   Lipsky, Peter E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; INTERLEUKIN 2; T2; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CALCINEURIN; CALMODULIN-BINDING PROTEINS; CELL CYCLE; CYTOKINES; DIGLYCERIDES; DRUGS, CHINESE HERBAL; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MITOGENS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEINS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRITIUM; TYROSINE; URIDINE;

EID: 0029940573     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. BERRIDGE, M. J., DAWNSON, R. M. C., DOWNES, C. P., HESLOP, J. P. AND IRVINE, R. F.: Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212: 473-482, 1983.
2. BIJSTERBISCH, M. K. AND KLAUS, G. G. B.: Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes. Immunology 56: 435-440, 1985.
3. BLUMENTHAL, D. K., TAKIO, K., HANSEN, R S. AND KREBS, E. G.: Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. J. Biol. Chem. 261: 8140-8145, 1986.
4. BRUNVAND, M. W., SCHMIDT, A. AND SIEBENLIST, U.: Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene. J. Biol. Chem. 263: 18904-18910, 1988.
5. CANTRELL, D. A. AND SMITH, K. A.: The interleukin-2 T-cell system: A new cell growth model. Science 224: 1312-1316, 1984.
6. CASTAGNA, M., TAKAI, Y., KAIBUCHI, K., SANO, K., KIKKAWA, U. AND NISHIZUKA, Y.: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257: 7847-7851, 1982.
7. CHANG, J. L., CHANG, X., GUO, J., NI, B. AND LI, B.: A preliminary study on the immunosuppressive activity of mixed glycoside of TWH. Chin. J. Microbiol. Immunol. 4: 331-334, 1984.
8. CHENG, Z Z.: The chemical ingredients of Triptorygium wilfordii Hook. In Investigation of Tripterygium wilfordii Hook, ed. by R. L. Li and D. F. Shu, pp. 47-74, Chinese Publisher of Sciences and Techniques, Beijing, 1989.
9. DARZYNKBIEWICZ, Z., TRACANOS, F., SHARPLESS, T. AND MELAMED, M. R.: Conformation of RNA in situ as studied by acridine orange staining and automated cytofluorometry. Exp. Cell. Res. 95: 143-153, 1975
10. DAVIS, L., VIDA, R. AND LIPSKY, P. E.: Regulation of human T lymphocyte mitogenesis by antibodies to CD3. J. Immunol. 137: 3758-3767, 1986.
11. DAVIS, L. S. AND LIPSKY, P. E.: T cell activation induced by anti-CD3 antibodies requires prolonged stimulation of protein kinase C. Cell. Immunol. 118: 208-221, 1989.
12. DURAND, D. B., SHAW, J. P., BUSH, M. R., REPLOGLE, R. E., BELAGAJE, R. AND CRABTREE, G. R.: Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell. Biol. 8:1715-1724, 1988.
13. EMMEL, E. A., VERWEIJ, C. L., DURAND, D B., HIGGINS, K. M., LACY, E. AND CRABTREE, G. R.: Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617-1620, 1989.
14. FRUMAN, D. A., KLEE, C B., BIERER, B. E. AND BURAKOFF, S. J.: Calcineurin phosphatase activity in T lymphocyte is inhibited by FK506 and cyclosporin A Proc Natl Acad. Sci. U.S.A. 89: 3686-3690, 1992.
15. GILLIS, S., FERM, M. M., OU, W. AND SMITH, K. A.: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol. 120: 2027-2032, 1978.
16. GLISIN, V., CRKVENJAKOV, R. AND BYUS, C.: Ribonucleic acid isolated by cesium chloride centrifugation Biochemistry 13: 2633-2637, 1974.
17. GORMAN, C. M., MOFFAT, L F AND HOWARD, B H.: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051, 1982.
18. GRANELLI-PIPERNO, A., ANDRUS, L. AND STEINMAN, R. M : Lymphokine and non-lymphokine mRNA levels in stimulated human T cells. J. Exp. Med 163: 922-937, 1986.
19. GRANELLI-PIPERNO, A., KEANE, M. AND STEINMAN, R. M.: Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation 46: (suppl.) 53s-60s, 1988.
20. GRANELLI-PIPERNO, A. AND NOLAN, P.: Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells. J. Immunol. 147: 2734-2739, 1991.
21. HOYOS, B., BALLARD, D. W., BOHNLEIN, E., SIEKEVITZ, M. AND GREENE, W. C.: Kappa B-specific DNA binding proteins. Role in the regulation of human interleukin-2 gene expression. Science 244: 457-460, 1989.
22. HASHIMOTO, K., WHITEHURST, C. E., MATASUBARA, T., HIROHADA, K. AND LIPSKY, P. E.: Immunomodulatory effect of therapeutic gold compounds gold sodium thiomalate inhibits the activity of T cell protein kinase C. J. Clin. Invest. 89: 1839-1848, 1992.
23. IMBODEN, B. J. AND STOBO, J. D : Transmembrane signalling by the T cell antigen receptor. J. Exp. Med. 161: 446-456, 1985.
24. JIA, L.: Chemistry and pharmacology and clinical application of the plants of triprerygium family Yao Xua Tong Bao 20: 101-105, 1985.
25. JUNE, C. H., FLETCHER, M. C., LEDBETTER, J. A., SCHIEVEN, G. L., SIEGEL, J. N., PHILLIPS, A. F. AND SAMELSON, L. E.: Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A 87: 7722-7726, 1990.
26. JUNE, C. H., FLETCHER, M C., LEDBETTER, J. A AND SAMELSON, L. E : Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144: 1591-1599, 1990.
27. KAMPS, M. P , CORCORAN, L., LEBOWITZ, J. H AND BALTIMORE, D.: The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10: 5464-5472, 1990.
28. KENNERLY, D. A., PARKER, C. W. AND SULLIVAN, T. J.: Use of diacylglycerol kinase to quantitate picomole levels of 1,2-diacylglycerol. Anal. Biochem. 98: 123-131, 1979.
29. KRONKE, M., LEONARD, W. J., DEPPER, J. M., ARYA, S. K., WONG-STAAL, F., GALLO, R. C., WALDMANN, T. A. AND GREENE, W C.: Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription Proc. Natl. Acad. Sci U.S.A. 81: 5214-5218, 1984.
30. KUMAGAI, N., BENEDICT, S. H., MILLA, G. B. AND GELFAND, E. W.: Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes. J. Immunol 139: 1393-1399, 1987.
31. KUMAGAI, N., BENEDICT, S H., MILLS, G. B. AND GELFAND, E. W.: Comparison of phobolester/calcium ionophore and phytohemagglutinin-induced signalling in human T lymphocytes. J. Immunol. 140: 37-43, 1988.
32. KUNKL, A. AND KLAUS, G. G. B.: Selective effects of cyclosporin A on functional B cell subsets in the mouse. J. Immunol. 125: 2526-2531, 1980.
33. LEONARD, W. J., DEPPER, J. M., CRABTREE, G. R., RUDIKOFF, S., PUMPHREY, J., ROBB, R. J., KRONKE, M., SVETLIK, P. B., PEFFER, N. J , WALDMANN, T. A. AND GREENE, W. C.: Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311: 626-635, 1984.
34. LEUNG, K. AND NABEL, G. J.: HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kB-like factor. Nature 333: 776-778, 1988.
35. LIBERMANN, T. A. AND BALTIMORE, D.: Activation of interleukin-6 gene expression through the NF-kB transcription factor. Mol. Cell. Biol. 10: 2327-2334, 1990.
36. LINSLEY, P. S , BRADY, W., GROSMAIRE, L., ARUFFO, A., DAMLE, N K. AND LEDBETTER, J. A.: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730, 1991.
37. LIU, J., FARMER, J. D., LANE, W. S., FRIEDMAN, J., WEISSMAN, F. AND SCHREIBER, S. L., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815, 1991.
38. MAKAR, R. S. J., LIPSKY, P. E. AND CUTHBERT, J. A., Non-sterol regulation of low density lipoprotein receptor gene expression in T cells. J. Lipid Res. 35: 1888-1895, 1994.
39. MILLS, G. B., CHEUNG, R. K., GRINSTEIN, S. AND GELFAND, E. W.: Increase in cytosolic free calcium concentration is an intracellular messenger for the production of interleukin 2 but not for expression of the interleukin 2 receptor. J. Immunol. 134: 1640-1643, 1985.
40. MUSTELIN, T., COGGESHALL, K M, ISAKOV, N. AND ALTMAN, A.: T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science 247: 1584-1587, 1990.
41. NISHIZUKA, Y.: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693-698, 1984.
42. OWAKI, H., VARMA, R., GILLIS, B., BRUDER, J. T., RAPP, U. R., DAVIS, L. S. AND GEPPERT, T. D.. Raf-1 is required for T cell IL-2 production. EMBO J. 12: 4367-4373, 1993.
43. PAAVONEN, T. AND HÄYRY, P.. Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro Nature 281: 542-546, 1980.
44. REED, J. C., PRYSTOWSKY, M. B. AND NOWELL, P. C.: Regulation of gene expression in lectin-stimulated or lymphokine-stimulated T lymphocyte. Transplantation 46: 85s-89s. suppl, 1988.
45. SEKIGUCHI, K, TSUKUDA, M., ASE, K., KIKKAWA, U. AND NISHIZUKA, Y.: Mode of activation and kinetic properties of three distinct forms of protein kinase C from rat brain. J. Biochem. 103: 759-765, 1988.
46. SHAND, N. AND RICHARDSON, B.: Sandimmune (cyclosporin A): Mode of action and clinical results in rheumatoid arthritis. Scand. J. Rheumatol. 76: 265-278, 1988.
47. SHARPLESS, T., TRAGANOS, F., DARZYNKIEWICZ, Z. AND MELAMED, M. R.: Flow cytofluorimetry: Discrimination between single cells and cell aggregates by direct size measurements. Acta Cytol. 19: 577-581, 1975.
48. SHAW, J P., UTZ, P. J., DURANS, D. B , TOOLE, J. J., EMMEL, E A. AND CRABTREE, G. R.: Identification of a putative regulator of early T cell activation genes. Science 241: 202-205, 1988.
49. SHIMIZU, H., MITOMO, K., WATANABE, T., OKAMOTO, S. AND YAMAMOTO, K-I.: Involvement of a NF-Kb-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell. Biol. 10: 561-568, 1990.
50. STANLEY, J. B , R. GORCZYNSKI, R., HUANG, C. K., LOVE, J. AND MILLS, G. B.: Tyrosine phosphorylation is an obligatory event in IL-2 secretion. J. Immunol. 145: 2189-2198, 1990.
51. TAO, X. L., SUN, Y , DONG, Y., SHI, Y. P., XIAO, Y. L., HU, D. W. AND CHANG, N. C.: Prospective controled, double blind, cross-over trial of T2 (polyglycosides extracted from tripterygium wilfordii Hook F) in the treatment of rheumatoid arthritis. Chin. J. Med 26: 399-402, 1987.
52. TAO, X. L., SHI, Y. P. AND CHANG, N. C.: Mechanism of treatment of rheumatoid arthritis with Tripterygium wilfordii Hook F. (1). Effect of T2 on secretion of total IgM and IgM-RF by PBMC. Acta Acad. Med. Sin. 10: 361-364, 1988.
53. TAO, X. L., DAVIS, L. S AND LIPSKY, P. E.: Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum. 34: 1274-1281, 1991.
54. TAO, X. L., CAI, J. J. AND LIPSKY, P. E.: Identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook F. J. Pharmacol. Exp. Ther. 272: 1305-1312, 1995.
55. THIELE, D. L , KUROSAKA, M. AND LIPSKY, P. E.: Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomoltropic agent, L-leucine methyl ester. J. Immunol. 131: 2282-2290, 1983
56. TRUNEH, A., ALBERT, F., GOLSTEIN, P. AND SCHMITT-VERHULST, A-M.: Early steps of lymphocyte activation bypass by synergy between calcium ionophores and phorbol ester. Nature 313: 318-320, 1985.
57. WEISS, A., IMBODEN, J., SHOBACK, D. AND STOBO, J.: Role of T3 surface molecules in human T-cell activation: T3 dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. U.S.A. 81: 4169-4173, 1984.
58. WEISS, A , IMBODEN, J., HARDY, K., MANGER, B , TERHORST, C. AND STOBO, J.: The role of the T3/antigen receptor complex in T-cell activation. Ann. Rev. Immunol. 4: 593-619, 1986.
59. WISKOCIL, R., WEISS, A., IMBODEN, J., KAMIN-LEWIS, R. AND STOBO, J.: Activation of a human T cell line. A two stimulatus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and γ-interferon genes. J. Immunol. 134: 1599-1603, 1985
60. ZHENG, J. R., XU, L., MA, L., WANG, D. AND GAO, J.: Studies on pharmacological actions of total Igycasides in Tripterygium wilfordii. Acta Acad. Med. Sin. 5: 1-6, 1983.